Colombo M, Sangiovanni A. Treatment of hepatocellular carcinoma: beyond international guidelines. Liver Int. 2015;35 Suppl 1:129-138.Colombo M and Sangiovanni A: Treatment of hepatocellular carcinoma: Beyond international guidelines. Liver Int 35 (Suppl 1): S129‑S138, 2015....
Current management of hepatocellular carcinoma Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and leading cause of death among patients with cirrhosis. Treatment guidelines are... P Tabrizian,S Roayaie,ME Schwartz - 《World Journal of Gastroenterology》 被引量: 227发表: ...
Treatment protocols for hepatocellular carcinoma are provided below, including those for patients with unresectable disease and patients with special considerations. Treatment recommendations for patients with early-stage resectable disease For patients
Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line treatment for unresectable hepatocellular carcinoma (uHCC): First results from CheckMate 9DW. 2024 ASCO Annual Meeting, LBA4008. Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, et al....
Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7:vii41–8. : 10.1093/annonc/mds225 .Verslype C, Rosmorduc O, Rougier P, Group EGW (2012) Hepatocellular carcinoma: ESMO-ESDO clinical practice ...
GUIDELINES Pocketcards(TM) are multifold pocketcards containing society-endorsed, evidence-based treatment guidelines in a brief algorithmic format that is most preferred by practicing clinicians, quality managers, nurses, educators, and medical students. "The Hepatocellular Carcinoma GUIDELINES Pocketcard(TM...
In the past 3 years, the FDA has approved 7 novel drugs, either given alone or in combination, to help treat patients with hepatocellular carcinoma. Renuka Iyer, MD In the past 3 years, the FDA has approved 7 novel drugs, either given alone or in combination, to help treat patients ...
There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the AsiaR
ocellular carcinoma Treatment of hepatocellular carcinomaTreatment of hepatocellular carcinomadoi:10.1002/jso.2930530520hepatocellularcarcinomatreatmentWileyJournal of Surgical Oncology
Dr. Gordan notedthat one of the most significant challenges in the treatment of hepatocellular carcinoma is the interface between treatment toxicity and patients’ baseline liver function. “Physicians must be aware that these recommendations are subject to a patient’s liver function ...